Glass House Brands Subordinate Voting Shares (GLAS) vs Ironwood Pharmaceuticals (IRWD)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Ironwood Pharmaceuticals (IRWD) has outperformed Glass House Brands Subordinate Voting Shares (GLAS) over the past year, gaining 144.9% versus a loss of 44.9%. Over five years, GLAS leads with a -11.7% price change compared with -72.5% for IRWD. Ironwood Pharmaceuticals is the larger company by market cap ($639.5 million vs $415.6 million), about 1.5 times the size.
On valuation, Ironwood Pharmaceuticals trades at a lower forward P/E (2.6x vs 19.6x for Glass House Brands Subordinate Voting Shares).
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | GLAS | IRWD |
|---|---|---|
| Share price | $4.41 | $3.87 |
| Market cap | $415.61M | $639.48M |
| 1-day change | -14.04% | +3.20% |
| YTD return | -50.17% | +14.84% |
| 1-year return | -44.88% | +144.94% |
| 5-year return | -11.71% | -72.55% |
| P/E ratio (TTM) | — | 5.03 |
| Forward P/E | 19.60 | 2.58 |
| EPS (TTM) | $-0.74 | $0.77 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $13.93 | $5.78 |
| 52-week low | $4.20 | $1.41 |
| Distance from 52-week high | -68.34% | -33.04% |
| Analyst consensus | none | none |
| Avg. price target upside | +262.81% | +57.62% |
| Average volume | 805.40K | 2.02M |
| Shares outstanding | 88.00M | 165.24M |
| Employees | 357 | 100 |
| Sector | Health Care | Health Care |
| Industry | Medicinal Chemicals and Botanical Products | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- IRWD has outperformed GLAS by 189.8 percentage points over the past year.
About Glass House Brands Subordinate Voting Shares
GLAS stock →Glass House Brands Inc., together with its subsidiaries, operates as an integrated cannabis company in the United States. It operates through three segments: Retail; Wholesale Biomass; and Cannabis-Related Consumer Packaged Goods.
Health Care · Medicinal Chemicals and Botanical Products · 357 employees
About Ironwood Pharmaceuticals
IRWD stock →Ironwood Pharmaceuticals, Inc., a biotechnology company, focuses on the development and commercialization of therapies for gastrointestinal (GI) and rare diseases in the United States and internationally. It sells linaclotide, a guanylate cyclase type-C (GC-C) agonist for the treatment of adults suffering from irritable bowel syndrome with constipation or chronic idiopathic constipation, as well as for pediatric patients suffering from functional constipation under the LINZESS and CONSTELLA names.
Health Care · Biotechnology: Pharmaceutical Preparations · 100 employees
GLAS vs IRWD FAQ
Which is bigger, Glass House Brands Subordinate Voting Shares or Ironwood Pharmaceuticals?
Ironwood Pharmaceuticals (IRWD) is larger, with a market capitalization of $639.48M compared with $415.61M for Glass House Brands Subordinate Voting Shares (GLAS).
Which stock has performed better over the past year, GLAS or IRWD?
IRWD returned +144.94% over the past 12 months, compared with -44.88% for GLAS (price return, excluding dividends). Past performance does not predict future results.
Are Glass House Brands Subordinate Voting Shares and Ironwood Pharmaceuticals in the same industry?
Both are in the Health Care sector, but in different industries: Medicinal Chemicals and Botanical Products for Glass House Brands Subordinate Voting Shares and Biotechnology: Pharmaceutical Preparations for Ironwood Pharmaceuticals.